AIA
PFE icon

AIMZ Investment Advisors’s Pfizer PFE Stock Holding History

AIMZ Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$391K Buy
13,930
+8
+0.1% +$213 0.12% 105
2025
Q4 		$347K Sell
13,922
-1,191
-8% -$30K 0.1% 113
2025
Q3 		$385K Sell
15,113
-622
-4% -$15.4K 0.12% 101
2025
Q2 		$381K Sell
15,735
-64
-0.4% -$1.49K 0.13% 100
2025
Q1 		$400K Buy
15,799
+297
+2% +$7.77K 0.14% 98
2024
Q4 		$411K Sell
15,502
-464
-3% -$12.6K 0.14% 95
2024
Q3 		$462K Sell
15,966
-34
-0.2% -$992 0.16% 88
2024
Q2 		$448K Sell
16,000
-233
-1% -$6.42K 0.16% 88
2024
Q1 		$450K Sell
16,233
-693
-4% -$19.2K 0.17% 86
2023
Q4 		$487K Sell
16,926
-29
-0.2% -$877 0.2% 82
2023
Q3 		$562K Buy
16,955
+6
+0% +$212 0.25% 72
2023
Q2 		$622K Buy
16,949
+4
+0% +$156 0.27% 71
2023
Q1 		$691K Sell
16,945
-160
-0.9% -$6.91K 0.31% 66
2022
Q4 		$876K Sell
17,105
-145
-0.8% -$6.95K 0.41% 62
2022
Q3 		$755K Sell
17,250
-46
-0.3% -$2.23K 0.38% 65
2022
Q2 		$907K Sell
17,296
-72
-0.4% -$3.67K 0.43% 64
2022
Q1 		$899K Buy
17,368
+3
+0% +$156 0.37% 68
2021
Q4 		$1.02M Buy
17,365
+3
+0% +$149 0.4% 70
2021
Q3 		$747K Buy
17,362
+143
+0.8% +$6.33K 0.34% 72
2021
Q2 		$674K Sell
17,219
-22
-0.1% -$856 0.3% 74
2021
Q1 		$625K Sell
17,241
-148
-0.9% -$5.25K 0.31% 72
2020
Q4 		$640K Sell
17,389
-794
-4% -$29.1K 0.34% 69
2020
Q3 		$633K Buy
18,183
+4
+0% +$140 0.38% 63
2020
Q2 		$564K Buy
18,179
+3
+0% +$102 0.37% 61
2020
Q1 		$563K Sell
18,176
-102
-0.6% -$3.48K 0.44% 61
2019
Q4 		$679K Sell
18,278
-525
-3% -$18.7K 0.44% 65
2019
Q3 		$641K Sell
18,803
-113
-0.6% -$4.11K 0.44% 66
2019
Q2 		$777K Buy
18,916
+2
+0% +$79 0.54% 57
2019
Q1 		$762K Sell
18,914
-314
-2% -$12.6K 0.52% 58
2018
Q4 		$796K Buy
19,228
+65
+0.3% +$2.7K 0.61% 56
2018
Q3 		$801K Buy
19,163
+2
+0% +$77 0.52% 59
2018
Q2 		$660K Buy
19,161
+2
+0% +$68 0.47% 64
2018
Q1 		$645K Sell
19,159
-109
-0.6% -$3.75K 0.47% 64
2017
Q4 		$662K Sell
19,268
-103
-0.5% -$3.51K 0.5% 61
2017
Q3 		$656K Buy
19,371
+2
+0% +$64 0.54% 60
2017
Q2 		$617K Sell
19,369
-337
-2% -$10.6K 0.52% 62
2017
Q1 		$640K Buy
19,706
+4
+0% +$126 0.54% 63
2016
Q4 		$607K Sell
19,702
-65
-0.3% -$1.98K 0.54% 60
2016
Q3 		$635K Buy
19,767
+2
+0% +$67 0.57% 59
2016
Q2 		$660K Sell
19,765
-18,787
-49% -$600K 0.61% 58
2016
Q1 		$1.18M Buy
38,552
+19,562
+103% +$559K 0.52% 62
2015
Q4 		$582K Buy
18,990
+2
+0% +$63 0.53% 61
2015
Q3 		$566K Buy
18,988
+2
+0% +$64 0.52% 61
2015
Q2 		$604K Buy
18,986
+254
+1% +$8.28K 0.52% 62
2015
Q1 		$618K Buy
18,732
+529
+3% +$16.8K 0.53% 56
2014
Q4 		$538K Buy
+18,203
New +$522K 0.48% 61

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AIMZ Investment Advisors's PFE Position: Q1 2026 in Review

AIMZ Investment Advisors increased its Pfizer (PFE) stake by 0.06% in Q1 2026, buying an estimated $213 and bringing the position to 13,930 shares worth $391K. The position accounts for 0.12% of the portfolio, ranked #105.

AIMZ Investment Advisors first reported a position in PFE in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.18M in Q1 2016. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • AIMZ Investment Advisors held 13,930 shares of Pfizer worth $391K as of Q1 2026.
  • AIMZ Investment Advisors bought 8 Pfizer shares in Q1 2026, an estimated $213.
  • Pfizer made up 0.12% of AIMZ Investment Advisors's portfolio in Q1 2026, its #105 holding.
  • AIMZ Investment Advisors first reported a position in Pfizer in Q4 2014 and has held it in 46 quarters since.
  • AIMZ Investment Advisors's Pfizer position peaked at $1.18M in Q1 2016.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on AIMZ Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.